Abstract
Purpose
To evaluate the treatment effect of strabismus surgery for Graves ophthalmopathy in an ethnic Chinese population.
Study design
A prospective clinical study.
Methods
Thirty-one patients with Graves ophthalmopathy who had undergone strabismus surgery at National Taiwan University Hospital between 2012 and 2013 were consecutively recruited. The subjective outcome was evaluated using the Graves’ Ophthalmopathy Quality-of-Life (GO-QoL) questionnaire, and the ocular deviation was measured preoperatively and postoperatively by use of a prism cover test.
Results
The GO-QoL scores for visual functioning and appearance improved significantly after surgery (preoperative scores 32.6 ± 19.9 and 43.8 ± 26.4, postoperative scores 55.2 ± 24.4 and 54.1 ± 27.6, respectively; P < .05). Motor success was achieved in 61.3% of the patients, and their postoperative visual scores were higher (61.5 ± 22.5) than the scores of those who experienced motor failure (45.3 ± 26.8, P = .048). The postoperative visual function scores showed a negative correlation with the residual vertical deviation (R2 = 0.546, P = .040). A higher increase in GO-QoL visual scores and a lower residual vertical deviation in downgaze were achieved among patients without previous decompression surgery. Our surgical methods resulted in a motor success rate of 76.5% for the correction of vertical deviation.
Conclusion
GO-QoL scores and ocular deviation improved significantly after strabismus surgery. Precise correction of vertical deviation was of greater importance than horizontal deviation for visual function scores. Our surgical methods were effective for the correction of vertical deviation in Graves ophthalmopathy.
Similar content being viewed by others
Data sharing Statement
The datasets analyzed during the current study are available from the corresponding author on reasonable request.
References
Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM. Development of a disease specific quality of life questionnaire for patients with Graves’ ophthalmopathy: the GO-QOL. Br J Ophthalmol. 1998;82:773–9.
Terwee CB, Gerding MN, Dekker FW, Prummel MF, van der Pol JP, Wiersinga WM. Test-retest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves’ ophthalmopathy. J Clin Epidemiol. 1999;52:875–84.
Terwee CB, Dekker FW, Mourits MP, Gerding MN, Baldeschi L, Kalmann R, et al. Interpretation and validity of changes in scores on the Graves’ ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clin Endocrinol (Oxf). 2001;54:391–8.
Terwee CB, Wakelkamp I, Tan S, Dekker F, Prummel MF, Wiersinga W. Long-term effects of Graves’ ophthalmopathy on health-related quality of life. Eur J Endocrinol. 2002;146:751–7.
Nasr E, Khater S, Nehme-Nasr D, Azoury F, Jambart S. Corticosteroids and radiotherapy in the treatment of Graves’ ophthalmopathy. J Med Liban. 2010;58:86–90.
Cheng AM, Wei YH, Tighe S, Sheha H, Liao SL. Long-term outcomes of orbital fat decompression in Graves’ orbitopathy. Br J Ophthalmol. 2018;102:69–73.
European Group on Graves’ Orbitopathy (EUGOGO), Mourits MP, Bijl H, Altea MA, Baldeschi L, Boboridis K, Currò N, et al. Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ orbitopathy using various surgical procedures. Br J Ophthalmol. 2009;93:1518–23.
Prummel MF, Terwee CB, Gerding MN, Baldeschi L, Mourits MP, Blank L, et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves’ ophthalmopathy. J Clin Endocrinol Metab. 2004;89:15–20.
Lin IC, Lee CC, Liao SL. Assessing quality of life in taiwanese patients with Graves’ ophthalmopathy. J Formos Med Assoc. 2015;114:1047–54.
Farid M, Roch-Levecq AC, Levi L, Brody BL, Granet DB, Kikkawa DO. Psychological disturbance in Graves’ ophthalmopathy. Arch Ophthalmol. 2005;123:491–6.
Yeatts RP. Quality of life in patients with Graves’ ophthalmopathy. Trans Am Ophthalmol Soc. 2005;103:368–411.
Coulter I, Frewin S, Krassas GE, Perros P. Psychological implications of Graves’ Orbitopathy. Eur J Endocrinol. 2007;157:127–31.
Garrity JA, Fatourechi V, Bergstralh EJ, Bartley GB, Beatty CW, DeSanto LW, et al. Results of transantral orbital decompression in 428 patients with severe Graves’ ophthalmopathy. Am J Ophthalmol. 1993;15:116:533–47.
Goldberg RA, Perry JD, Hortaleza V, Tong JT. Strabismus after balanced medial plus lateral wall versus lateral wall only orbital decompression for dysthyroid orbitopathy. Ophthalmic Plast Reconstr Surg. 2000;16:271–7.
Ben Simon GJ, Syed HM, Lee S, Wang DY, Schwarcz RM, McCann JD, et al. Strabismus after deep lateral wall orbital decompression in thyroid-related orbitopathy patients using automated Hess screen. Ophthalmology. 2006;113:1050–5.
Sasim IV, Berendschot TT, van Isterdael C, Mourits MP. Planning health care for patients with Graves’ orbitopathy. Graefes Arch Clin Exp Ophthalmol. 2008;246:1315–21.
Jellema HM, Saeed P, Mombaerts I, Dolman PJ, Garrity J, Kazim M, et al. Objective and subjective outcomes of strabismus surgery in Graves’ orbitopathy: a prospective multicentre study. Acta Ophthalmol. 2017;95:386–91.
Jellema HM, Merckel-Timmer E, Kloos R, Saeed P, Mourits MP. Quality of life improves after strabismus surgery in patients with Graves’ orbitopathy. Eur J Endocrinol. 2014;170:785–9.
Liao SL, Wei YH, Chuang AYC. The role of rectus muscle myectomy in the management of large-angle strabismus for Graves’ ophthalmopathy. Eye (Lond). 2017;31:1027–33.
Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol. 1997;47:9–14.
Honglertnapakul W, Cavuoto KM, McKeown CA, Capó H. Surgical treatment of strabismus in thyroid eye disease: characteristics, dose-response, and outcomes. J AAPOS. 2020;24:72e1–7.
Bradley EA, Sloan JA, Novotny PJ, Garrity JA, Woog JJ, West SK. Evaluation of the National Eye Institute visual function questionnaire in Graves’ ophthalmopathy. Ophthalmology. 2006;113:1450–4.
Bharadwaj SR, Hoenig MP, Sivaramakrishnan VC, Karthikeyan B, Simonian D, Mau K, et al. Variation of binocular-vertical fusion amplitude with convergence. Invest Ophthalmol Vis Sci. 2007;48:1592–600.
Lee JKS, Hsieh C, Wei YH, Liao SL. The impact of orbital bony or fat decompression on the outcome of strabismus surgery in patients with Graves’ ophthalmopathy. J Formos Med Assoc. 2019;118:387–94.
Kim MH, Park KA, Oh SY. The effect of previous orbital decompression on results of strabismus surgery in patients with Graves’ ophthalmopathy. J AAPOS. 2013;17:188–91.
Akbari MR, Mirmohammadsadeghi A, Mahmoudzadeh R, Veisi A. Management of thyroid eye disease-related strabismus. J Curr Ophthalmol. 2020;23:32:1–13.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Y.Y. Chen, None; Y. H. Wei, None; S. L. Liao, None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Corresponding Author: Shu-Lang Liao
About this article
Cite this article
Chen, YY., Wei, YH. & Liao, SL. Postoperative residual vertical deviation affects quality of life in Asian patients with thyroid-associated ophthalmopathy (Graves ophthalmopathy). Jpn J Ophthalmol 67, 326–334 (2023). https://doi.org/10.1007/s10384-023-00990-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-023-00990-z